Singapore markets closed

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.4100+0.0100 (+0.23%)
At close: 04:00PM EDT
4.4100 0.00 (0.00%)
Pre-market: 09:02AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-11,414
-98,298
-14,048
-8,084
-12,683
Depreciation & amortisation
10.4
10.4
9.868
10.4
10.4
Deferred income taxes
-8,432
-9,479
0
0
-
Stock-based compensation
3,954
1,193
3,525
4,142
3,831
Change in working capital
5,242
2,600
8,292
-1,020
3,110
Accounts payable
3,817
2,406
6,617
-311.862
-601.474
Other working capital
-1,695
-8,721
-1,495
-5,076
-5,110
Other non-cash items
105.385
1,919
119.41
317.833
288.366
Net cash provided by operating activities
-1,695
-8,721
-1,495
-5,076
-5,110
Cash flows from financing activities
Common stock issued
-
18,114
0
0
3,000
Common stock repurchased
-
-10,703
0
-
-
Other financing activities
-
-2,423
-99.14
-
-141.404
Net cash used provided by (used for) financing activities
1,353
5,956
1,865
5,230
4,560
Net change in cash
-342.024
-2,765
370.743
153.911
-549.756
Cash at beginning of period
944.775
5,902
328.581
174.67
724.426
Cash at end of period
602.751
3,138
699.324
328.581
174.67
Free cash flow
Operating cash flow
-1,695
-8,721
-1,495
-5,076
-5,110
Free cash flow
-1,695
-8,721
-1,495
-5,076
-5,110